Northwestern Medicine
Chicago, Illinois, 60611, United States
Location status: Recruiting
Location contact
Alyssa McDonald
CONTACT
NCT Number: NCT06531473
The primary aim is to assess the impact of laser setting frequency and wattage during holmium laser enucleation of the prostate. There is currently no gold-standard laser settings for HoLEP procedures. In the investigator's current high-volume practice, the following settings for enucleation are: 2j 50hz. These settings are conventional settings, but there is no literature to prove optimal laser settings. The investigators hypothesizes that utilization of higher laser settings may be associated with a clinically significant (defined as > 10%) decrease in procedural time without any detrimental postoperative outcomes, and a utilization of lower laser settings may be associated with a clinically significant (defined as >10%) reduction in postoperative irritative voiding symptoms without any detrimental postoperative outcomes.
Interested in participating?
Request Info18 year–89 year
Male
Interventional
Not applicable
Chicago, Illinois, 60611, United States
Location status: Recruiting
Alyssa McDonald
CONTACT
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients will be randomized to one of the laser energy groups day of surgery.
Time frame: 2 years
Comparing operative outcomes between the 40 hz, 50 hz and 60 hz laser setting groups.
Contact information is provided by the study sponsor or research team.
Allaa Fadl-Alla, BS
CONTACT
Alyssa McDonald, MS
CONTACT
Northwestern University
Other
Laser Outcomes Associated With HoLEP Procedures
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03258658
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
San Francisco, California, United States
View Trial DetailsNCT05878951
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Chicago, Illinois, United States
View Trial DetailsNCT07435844
Calcinosis, Calcium Metabolism Disorders
Mariánské Lázně, Carlsbad Region, Czechia
View Trial DetailsNCT05989646
Behavior, Behavioral Symptoms
Aalborg, Denmark
View Trial Details